ERBB4 and neoplasm: Also consistent with published data [42, 44], the K751M mutation, which disrupts tyrosine kinase activity, disrupts the tumor suppressor activity of the ErbB4 Q646C mutant in the MCF7 and MCF10A cells (Figure 2, Table 1 and Table 2).